Trials / Sponsors / Ellipses Pharma
Ellipses Pharma
Industry · 6 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Study to Evaluate the Safety and Tolerability of EP0089 Solid Cancers, Solid Tumours | Phase 1 / Phase 2 | 2025-09-01 |
| Withdrawn | EP0057 in Combination With Olaparib in Relapsed Advanced Gastric Cancer and Small Cell Lung Cancer Gastric Cancer, Small-cell Lung Cancer | Phase 2 | 2023-04-01 |
| Recruiting | Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic A Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer | Phase 1 / Phase 2 | 2023-01-11 |
| Recruiting | A Study of EP0031 in Patients With Advanced RET-altered Malignancies Advanced Solid Tumor, NSCLC | Phase 1 / Phase 2 | 2022-09-30 |
| Completed | EP0057 in Combination With Olaparib in Advanced Ovarian Cancer Ovarian Cancer | Phase 2 | 2020-12-14 |
| Recruiting | Study to Evaluate the Safety and Tolerability of EP0042 Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2020-11-02 |